[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Davies et al., 1983 - Google Patents

Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime

Davies et al., 1983

Document ID
16658234044738751370
Author
Davies B
Maesen F
Van Noord J
Publication year
Publication venue
Journal of Antimicrobial Chemotherapy

External Links

Snippet

Two groups of patients were treated with ceftazidime intramuscularly for 10 days. There were 34 patients with acute purulent exacerbations of chronic bronchitis of whom 20 received 1-g and the other 14 2-g injections. A further 38 patients with chronic recurrent …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms
    • Y10S435/822—Micro-organisms using bacteria or actinomycetales

Similar Documents

Publication Publication Date Title
Eliopoulos et al. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
DE69527195T2 (en) ANTI GRAM POSITIVE BACTERIAL PROCESS AND MEANS
Griffith et al. Cefamandole: in vitro and clinical pharmacokinetics
Davies et al. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime
Francke et al. Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms
JP2002500189A (en) Use of an antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament for the treatment of nosocomial microbial infections
Fisher et al. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli
Maesen et al. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis
Hodges et al. Cephacetrile: clinical evaluation in 27 patients
Bartlett Experimental aspects of intraabdominal abscess
Rothenbekg et al. Comparison of the efficacy of therapeutic agents in the treatment of experimentally induced diffuse peritonitis of intestinal origin
Klepser et al. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods
Jenkinson et al. Cefotaxime in the treatment of pneumococcal pneumonia
DE60222298T2 (en) METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS WITH GEMIFLOXACIN OR ON ITS SALT AND A BETA-LACTAM ANTIBIOTICUM
Beeuwkes et al. A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae
Ballantyne Cefadroxil in the treatment of skin and soft tissue infections
Holm et al. Comparative study of the penetration of penicillin V and cefadroxil into tonsils in man
Davies et al. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections
Hahn et al. Ceftriaxone, a new parenteral cephalosporin, in the treatment of urinary tract infections
Sabath Six factors that increase the activity of antibiotics in vivo
Karachalios et al. Treatment of acute pyelonephritis in women with intramuscular ceftriaxone: an out-patient study
Brogden et al. Amoxycillin: A Preliminary Report of its Pharmokinetic Properties and Therapeutic Efficacy
Ruedy A clinical trial of cephaloridine
Cohen et al. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections
Hoopes et al. Sliver lactate burn cream